Jane-Yi Meng, MD
Internal Medicine · Mountain View
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Office
- 1
Offices
1 location
Looking this up.
Hospitals listed: El Camino Health. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Meng’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A88281 · Current
Licensed to practise in California · since 2004 · expires 2027-11-30 · National Yang-Ming Medical College.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- El Camino HealthMountain View, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of El Camino Health, which runs 2 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.291, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0, Oct 2024 – Sep 2025
See every measure and the patient survey for El Camino Health
Behind the star rating — Deaths: 3 better, 5 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.291 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.96 (0.12 to 1.79) · 2,340 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.76 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 167.38 (125.03 to 209.73) · 96 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 185 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 814 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13 · 842 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 361 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 4,633 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.34) · 11,474 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.1 to 0.45) · 11,626 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.14 (1.39 to 4.9) · 2,814 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2 (0.61 to 3.39) · 1,327 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.8 to 3.43) · 2,641 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.39 (4.18 to 14.6) · 1,287 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.57 (3.47 to 9.68) · 1,308 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.14 (0.71 to 3.57) · 827 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.6 (0.05 to 1.15) · 9,460 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.5 · 122 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.993 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.706 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.376 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 218 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 962 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 3.8 · 200 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -17 · 922 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 18.6 · 860 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.7 · 827 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.1 (4.5 to 8.2) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.4 (10.6 to 16.5) · 313 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 144 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.7 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (10 to 16.1) · 1,639 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.8 to 1.1) · 1,619 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,535 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$12,787
Medicare paid this office $12,787 for 33 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 30 | $6,778 | $72 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 21 | $3,300 | $157 |
| Influenza vaccine split virus, preservative free | 20 | $1,636 | $82 |
| Administration of influenza virus vaccine | 20 | $781 | $39 |
Who their Medicare patients are
33 Original Medicare patients in 2024. Average age 73 · Under 65 0% · Women 67% · Also on Medicaid 0% · Health risk score 0.59. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75%.
The office billed $40,320, Medicare allowed $16,438 and paid $12,787; for 158 services of 6 kinds; $1,636 of it was for drugs given in the office and $11,150 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 33 | 158 | 73 | 0.59 | $40,320 | $12,787 |
| 2023 | 30 | 158 | 72 | 0.60 | $34,250 | $13,714 |
| 2022 | 36 | 157 | 72 | 0.64 | $29,995 | $13,276 |
| 2021 | 40 | 186 | 71 | 0.60 | $29,505 | $14,374 |
| 2020 | 39 | 126 | 69 | 0.56 | $22,430 | $8,044 |
| 2019 | 37 | 142 | 70 | 0.61 | $21,060 | $10,204 |
| 2018 | 44 | 160 | 69 | 0.67 | $24,480 | $11,131 |
| 2017 | 39 | 153 | 69 | 0.65 | $22,295 | $9,814 |
| 2016 | 44 | 148 | 69 | 0.60 | $21,535 | $9,893 |
| 2015 | 42 | 167 | 70 | 0.67 | $24,550 | $12,007 |
| 2014 | 40 | 137 | 70 | 0.75 | $20,480 | $9,555 |
| 2013 | 46 | 161 | 75 | 0.86 | $23,865 | $11,862 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Short return visit (20+ min) | 30 | $5,269 | $68 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $4,053 | $156 |
| Influenza vaccine split virus, preservative free | 19 | $1,367 | $72 |
| Administration of influenza virus vaccine | 19 | $702 | $37 |
2022: 4 services
| Short return visit (20+ min) | 35 | $6,823 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 25 | $3,978 | $159 |
| Influenza vaccine split virus, preservative free | 16 | $1,097 | $69 |
| Administration of influenza virus vaccine | 16 | $631 | $37 |
2021: 6 services
| Short return visit (20+ min) | 33 | $6,050 | $62 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $3,708 | $161 |
| Pneumococcal vaccine, 23-valent | 11 | $1,373 | $125 |
| Influenza vaccine split virus, preservative free | 11 | $718 | $65 |
| Administration of influenza virus vaccine | 14 | $303 | $22 |
| Administration of pneumococcal vaccine | 11 | $236 | $21 |
2020: 3 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,549 | $134 |
| Short return visit (20+ min) | 30 | $2,253 | $36 |
| Return visit (30+ min) | 23 | $1,464 | $49 |
2019: 5 services
| Return visit (30+ min) | 30 | $3,143 | $73 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 20 | $2,642 | $132 |
| Short return visit (20+ min) | 18 | $1,718 | $57 |
| Administration of influenza virus vaccine | 17 | $349 | $21 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $224 | $19 |
2018: 6 services
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 23 | $2,887 | $126 |
| Return visit (30+ min) | 31 | $2,682 | $65 |
| Short return visit (20+ min) | 21 | $1,949 | $48 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 11 | $1,939 | $176 |
| Administration of influenza virus vaccine | 14 | $360 | $26 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $261 | $19 |
2017: 5 services
| Short return visit (20+ min) | 23 | $3,228 | $49 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 26 | $3,188 | $123 |
| Return visit (30+ min) | 20 | $1,258 | $55 |
| Administration of influenza virus vaccine | 12 | $387 | $32 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $224 | $19 |
2016: 5 services
| Short return visit (20+ min) | 24 | $2,820 | $52 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 18 | $2,261 | $126 |
| Return visit (30+ min) | 22 | $1,816 | $67 |
| Administration of influenza virus vaccine | 14 | $421 | $30 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 14 | $256 | $18 |
2015: 5 services
| Short return visit (20+ min) | 24 | $3,032 | $55 |
| Return visit (30+ min) | 24 | $2,342 | $69 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 17 | $2,178 | $128 |
| Administration of influenza virus vaccine | 14 | $421 | $30 |
| Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | 12 | $213 | $18 |
2014: 4 services
| Return visit (30+ min) | 25 | $2,330 | $69 |
| Short return visit (20+ min) | 19 | $1,954 | $51 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 11 | $1,409 | $128 |
| Administration of influenza virus vaccine | 12 | $353 | $29 |
2013: 4 services
| Short return visit (20+ min) | 32 | $4,496 | $56 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 16 | $2,024 | $127 |
| New patient visit (45+ min) | 15 | $1,858 | $124 |
| Return visit (30+ min) | 12 | $1,235 | $82 |
Drugs they prescribed that Part D paid
$5,981
Pharmacies billed $5,981 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 251) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
228 generic and fewer than 11 brand-name prescriptions · $5,981 in drug cost · 23 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Atorvastatin | 33 | $426 | $13 |
| Rosuvastatin | 31 | $351 | $11 |
| Losartan | 41 | $273 | $7 |
| Metformin | 24 | $220 | $9 |
| Losartan-Hydrochlorothiazide | 11 | $155 | $14 |
See all 7 drugs
| Atorvastatin | 33 | $426 | $13 |
| Rosuvastatin | 31 | $351 | $11 |
| Losartan | 41 | $273 | $7 |
| Metformin | 24 | $220 | $9 |
| Losartan-Hydrochlorothiazide | 11 | $155 | $14 |
| Azithromycin | 13 | $82 | $6 |
| Levothyroxine | 15 | $30 | $2 |
Year by year
| 2024 | 251 | 32 | 0% (0) | None | $5,981 |
| 2023 | 225 | 29 | 0% (0) | None | $5,225 |
| 2022 | 238 | 32 | 0% (0) | None | $8,717 |
| 2021 | 247 | 29 | 0% (0) | 8% | $13,411 |
| 2020 | 285 | 35 | 0% (0) | 9% | $16,898 |
| 2019 | 188 | 30 | 0% (0) | 10% | $10,687 |
| 2018 | 195 | 31 | 0% (0) | 16% | $16,340 |
| 2017 | 163 | 28 | 0% (0) | 22% | $14,387 |
| 2016 | 197 | 32 | 0% (0) | 18% | $14,267 |
| 2015 | 164 | 33 | 0% (0) | 18% | $4,897 |
| 2014 | 156 | 26 | 0% (0) | 17% | $6,249 |
| 2013 | 236 | 29 | 0% (0) | 17% | $12,909 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 6 drugs
| Rosuvastatin | 30 | $539 | $18 |
| Atorvastatin | 36 | $411 | $11 |
| Losartan | 35 | $357 | $10 |
| Metformin | 20 | $216 | $11 |
| Losartan-Hydrochlorothiazide | 13 | $180 | $14 |
| Levothyroxine | 15 | $79 | $5 |
2022: 7 drugs
| Rosuvastatin | 35 | $662 | $19 |
| Losartan | 41 | $320 | $8 |
| Amlodipine Besylate | 18 | $299 | $17 |
| Metoprolol | 14 | $291 | $21 |
| Atorvastatin | 38 | $225 | $6 |
| Levothyroxine | 12 | $97 | $8 |
| Metformin | 14 | $19 | $1 |
2021: 6 drugs
| Rosuvastatin | 30 | $932 | $31 |
| Losartan | 37 | $476 | $13 |
| Atorvastatin | 52 | $346 | $7 |
| Amlodipine Besylate | 25 | $207 | $8 |
| Metformin | 13 | $51 | $4 |
| Atenolol | 13 | $24 | $2 |
2020: 7 drugs
| Rosuvastatin | 16 | $882 | $55 |
| Atorvastatin | 59 | $757 | $13 |
| Losartan | 38 | $534 | $14 |
| Metoprolol | 11 | $332 | $30 |
| Amlodipine Besylate | 28 | $214 | $8 |
| Alendronate | 11 | $159 | $14 |
| Metformin | 16 | $116 | $7 |
2019: 3 drugs
| Atorvastatin | 43 | $781 | $18 |
| Losartan | 17 | $302 | $18 |
| Amlodipine Besylate | 17 | $127 | $7 |
2018: 4 drugs
| Atorvastatin | 40 | $924 | $23 |
| Levothyroxine | 19 | $676 | $36 |
| Losartan | 20 | $259 | $13 |
| Amlodipine Besylate | 20 | $212 | $11 |
2017: 3 drugs
| Valsartan | 12 | $667 | $56 |
| Atorvastatin | 33 | $611 | $19 |
| Amlodipine Besylate | 22 | $318 | $14 |
2016: 4 drugs
| Atorvastatin | 52 | $1,293 | $25 |
| Amlodipine Besylate | 31 | $352 | $11 |
| Lisinopril | 15 | $158 | $11 |
| Losartan | 11 | $150 | $14 |
2015: 5 drugs
| Atorvastatin | 34 | $796 | $23 |
| Amlodipine Besylate | 21 | $138 | $7 |
| Losartan | 11 | $115 | $10 |
| Metoprolol | 13 | $101 | $8 |
| Temazepam | 11 | $53 | $5 |
2014: 2 drugs
| Atorvastatin | 33 | $749 | $23 |
| Levothyroxine | 11 | $194 | $18 |
2013: 8 drugs
| Diovan | 18 | $4,564 | $254 |
| Atorvastatin | 33 | $1,182 | $36 |
| Fluticasone Propionate | 11 | $225 | $20 |
| Losartan | 13 | $221 | $17 |
| Amlodipine Besylate | 15 | $140 | $9 |
| Metoprolol | 17 | $111 | $7 |
| Hydrochlorothiazide | 13 | $77 | $6 |
| Temazepam | 11 | $53 | $5 |
Professional record
- NPI
- 1821045774
- Licence
- CA A88281California A88281: Current · expires 2027-11-30
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 2485 Hospital Dr, Orchard Pavilion Ste # 240, Mountain View, CA, 94040
- NPI first listed
- 2006-05-27
- NPI last updated
- 2007-08-07
This is when the NPI record was last certified, not a medical board exam.